Sort
40,608 grants matching “prostate cancer”
Development of a salt-based nanomedicine for non-muscle invasive bladder cancer
$399,907Zhi Liu · Athna Biotech, Inc. · R43 · FY2022 · CA
Minimally invasive quantitative tissue oxygen sensors to personalize cancer care
$399,888Gregory Ekchian · Stratagen Bio, Inc. · R43 · FY2023 · CA
Cell Growth Signaling in Cancer Development
$399,870David M Sabatini · Whitehead Institute For Biomedical Res · R01 · FY2008 · CA
TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD
$399,866Syamal Ratchaudhuri · Inbios International, Inc. · N43 · FY2024 · CA
Understanding How Thiolates Promote Dioxygen Chemistry
$399,795Julia A Kovacs · University Of Washington · R01 · FY2020 · GM
Understanding How Thiolates Promote Dioxygen Chemistry
$399,795Julia A Kovacs · University Of Washington · R01 · FY2021 · GM
Understanding How Thiolates Promote Dioxygen Chemistry
$399,795Julia A Kovacs · University Of Washington · R01 · FY2019 · GM
ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE
$399,791Johns Hopkins University · R01 · FY2000 · CA
Discovery of bioactive peptides targeting ion channels upregulated in cancer
$399,768Ingrid Schroeder · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Quantitative oxygen sensing to enable personalized oncology treatment planning
$399,740Gregory Ekchian · Stratagen Bio, Inc. · R43 · FY2021 · CA
Genomic Enhancers at 8q24 and Prostate Cancer
$399,702Gerhard A Coetzee · University Of Southern California · R01 · FY2014 · CA
Structure and Function of CTCF: Mouse Model Studies
$399,688Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Radio-immunotherapy dose-painting (RAID) treatment for hormonal resistant prostate cancer
$399,680Adam Shilling · Nanocan Therapeutics Corporation · R42 · FY2022 · CA
Development of a novel personalized medicine platform using apheretically isolated circulating tumor cells to assess drug responsiveness in prostate cancer
$399,678Jayant Parthasarathy · Astrin Biosciences, Inc. · R41 · FY2022 · CA
Controlled Release of Macromolecules
$399,667Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2012 · EB
Community Outreach & Engagement
$399,648Jason A Mendoza · Fred Hutchinson Cancer Center · P30 · FY2022 · CA
Community Outreach & Engagement
$399,648Jason A Mendoza · Fred Hutchinson Cancer Center · P30 · FY2023 · CA
Community Outreach & Engagement
$399,647Jason A Mendoza · Fred Hutchinson Cancer Center · P30 · FY2024 · CA
1,3-Thioureas as First In Class Mitochondrial Inhibitors to Treat Oral Cancer
$399,635Cara B Gonzales · Keraceuticals, Inc. · R41 · FY2024 · DE
Harnessing Coded Ptychography to Deliver AI-powered Evaluation of Unstained Lung Biopsies at the Point-Of-Care
$399,583Torsten Lyon · Pathware Inc. · R43 · FY2022 · CA
PSYCHOSTIMULANTS FOR FATIGUE IN AMBULATORY MEN WITH PC
$399,583Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA
NGF Receptor Regulates Prostate Growth
$399,579Daniel Djakiew · Georgetown University · R56 · FY2009 · DK
Health Promotion for Positives: A Randomized Trial with HIV Positive Black Men
$399,544John Barton Jemmott · University Of Pennsylvania · R01 · FY2014 · MD
Health Promotion for Positives: A Randomized Trial with HIV Positive Black Men
$399,530John Barton Jemmott · University Of Pennsylvania · R01 · FY2015 · MD
Postdoctoral Training Program in Cancer Epidemiology
$399,513Northwestern University · R25 · FY2005 · CA